ARCHIVES

ImClone: Waksals To Pay $5 Million To Settle With SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 04 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004